BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29445067)

  • 1. Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.
    Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Matsumoto M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
    Circ J; 2018 Mar; 82(4):1121-1129. PubMed ID: 29445067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.
    Furuhashi M; Ogura M; Matsumoto M; Yuda S; Muranaka A; Kawamukai M; Omori A; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Harada-Shiba M; Shimamoto K; Miura T
    Sci Rep; 2017 Mar; 7(1):217. PubMed ID: 28303004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis.
    Tan M; Korkmaz H; Aydın H; Kumbul Doğuç D
    Turk J Med Sci; 2019 Oct; 49(5):1490-1497. PubMed ID: 31651119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
    Furuhashi M; Omori A; Matsumoto M; Kataoka Y; Tanaka M; Moniwa N; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    Am J Cardiol; 2016 Jul; 118(2):198-203. PubMed ID: 27241838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients.
    Parra S; Cabré A; Marimon F; Ferré R; Ribalta J; Gonzàlez M; Heras M; Castro A; Masana L
    Lupus; 2014 Mar; 23(3):245-54. PubMed ID: 24390652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
    Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
    Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.
    Fuseya T; Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Mita T; Ishimura S; Watanabe Y; Hoshina K; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    Cardiovasc Diabetol; 2014 Aug; 13():126. PubMed ID: 25142635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
    Tanaka M; Takahashi S; Higashiura Y; Sakai A; Koyama M; Saitoh S; Shimamoto K; Ohnishi H; Furuhashi M
    J Diabetes Investig; 2022 May; 13(5):878-888. PubMed ID: 34889064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study.
    Kozakova M; Natali A; Dekker J; Beck-Nielsen H; Laakso M; Nilsson P; Balkau B; Ferrannini E;
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1409-17. PubMed ID: 23599442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men.
    Tivesten A; Hulthe J; Wallenfeldt K; Wikstrand J; Ohlsson C; Fagerberg B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4433-7. PubMed ID: 16940451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study.
    Saito N; Furuhashi M; Koyama M; Higashiura Y; Akasaka H; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Ura N; Shimamoto K; Miura T
    Sci Rep; 2021 Feb; 11(1):4008. PubMed ID: 33597568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific associations between adipokine profiles and carotid-intima media thickness in the Cameron County Hispanic Cohort (CCHC).
    Kim D; Memili A; Chen HH; Highland HM; Polikowsky HG; Anwar MY; Laing ST; Lee M; McCormick JB; Fisher-Hoch SP; Below JE; North KE; Gutierrez AD
    Cardiovasc Diabetol; 2023 Aug; 22(1):231. PubMed ID: 37653519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.
    Okazaki Y; Furuhashi M; Tanaka M; Mita T; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    PLoS One; 2014; 9(12):e115429. PubMed ID: 25506691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thickened carotid intima media thickness and carotid atherosclerosis among lupus nephritis patients: the role of traditional and lupus-specific factors.
    Sazliyana S; Mohd Shahrir MS; Kong NC; Tan HJ; Hamidon BB; Azmi MT
    Int J Rheum Dis; 2011 Aug; 14(3):267-75. PubMed ID: 21816023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Tsanikidis H; Vitta I; Karkos C; Karayannacos PE; Gerasimidis T; Liapis CD
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):75-80. PubMed ID: 19834878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
    Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
    Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis.
    Yeung DC; Wang Y; Xu A; Cheung SC; Wat NM; Fong DY; Fong CH; Chau MT; Sham PC; Lam KS
    Eur Heart J; 2008 Sep; 29(17):2156-63. PubMed ID: 18603624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
    Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
    Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
    PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.